Equity Profile

COO

The Cooper Companies, Inc.

Health CareHealth Care Supplies$14.9B

Jun4Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

The Cooper Companies, Inc. (COO) operates in the health care sector, focusing on health care supplies, particularly in the field of contact lenses and surgical instruments....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

$1.10

Revenue

Revenue growth reflects the company's ability to increase sales and expand its market presence, which is crucial for long-term success.

$1.1B

Wall Street expectations, options signals, track record, and call prep available with Pro.

COO Q2-2026 Earnings Preview

Context

Company Snapshot

The Cooper Companies, Inc. (COO) operates in the health care sector, focusing on health care supplies, particularly in the field of contact lenses and surgical instruments. As a significant player in this industry, the company is influenced by trends in consumer health spending and advancements in medical technology.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+38.00%

Avg Stock Reaction

-0.40%

Last Quarter Recap

In Q1-2026, Cooper Companies reported an EPS of $1.18, surpassing estimates by 14.79%. However, the stock fell 2.17% the following day, indicating some market skepticism despite the positive earnings surprise.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Cooper Companies to report solid earnings and revenue for Q2-2026, with a consensus EPS of $1.10. The market is closely watching how the company continues to navigate challenges in the health care sector.

Bull Case

If Cooper Companies can exceed the EPS estimate and show strong revenue growth, it could signal robust demand for its products and lead to positive investor sentiment.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could raise concerns about its growth prospects and lead to a decline in stock price.

Key Metrics to Watch

EPS

$1.10

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

Revenue

$1.1B

Revenue growth reflects the company's ability to increase sales and expand its market presence, which is crucial for long-term success.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS exceed the consensus estimate of $1.10?

A beat on EPS would reinforce the company's profitability and could drive positive sentiment among investors.

What are the revenue growth expectations for this quarter?

Revenue growth is critical for assessing the company's market performance and future outlook, especially in a competitive health care environment.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate the impact of new product launches that could drive higher-than-expected revenue growth this quarter.

Supporting Evidence

The company has a strong track record of beating EPS estimates, suggesting potential for another surprise.

Options pricing indicates a significant expected move, which may reflect underlying bullish sentiment not captured in analyst estimates.

Key Risk

If revenue growth significantly outpaces expectations, it could challenge the current consensus view.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it will reflect the company's resilience in a challenging market and its ability to capitalize on growth opportunities.

Bull Confirmed If

An EPS of $1.15 or higher would confirm strong operational performance and investor confidence.

Bear Confirmed If

An EPS below $1.05 would raise concerns about the company's ability to maintain profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±10.43%

Historical Avg

±0.9%

Pricing rich

The options market is pricing in a significant move in either direction, indicating that traders expect volatility around the earnings report.

Options are pricing ±10.4% while COO has averaged ±0.9% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

23.8%

Calls (34K)P/C Ratio: 3.83Puts (11K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cooper Companies beats expectations, history suggests a potential stock increase of around 0.95%, confirming strong operational strength.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss could lead to a decline in stock price, with historical data suggesting a potential drop of around 0.40%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's outlook on market conditions and competitive pressures in the health care sector.
3Details on cost management strategies and their effects on profitability.
4Insights into customer demand trends and how they are influencing sales.
5Any commentary on supply chain stability and its impact on operations.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jun1

CRDOAMC

Credo Technology Group Holding Ltd

PreviewView

Jun1

HPEAMC

Company Snapshot

The Cooper Companies, Inc. (COO) operates in the health care sector, focusing on health care supplies, particularly in the field of contact lenses and surgical instruments....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

$1.10

Revenue

Revenue growth reflects the company's ability to increase sales and expand its market presence, which is crucial for long-term success.

$1.1B

Wall Street expectations, options signals, track record, and call prep available with Pro.

COO Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+38.00%

Avg Stock Reaction

-0.40%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Cooper Companies can exceed the EPS estimate and show strong revenue growth, it could signal robust demand for its products and lead to positive investor sentiment.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could raise concerns about its growth prospects and lead to a decline in stock price.

Key Metrics to Watch

EPS

$1.10

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

Revenue

$1.1B

Revenue growth reflects the company's ability to increase sales and expand its market presence, which is crucial for long-term success.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS exceed the consensus estimate of $1.10?

A beat on EPS would reinforce the company's profitability and could drive positive sentiment among investors.

What are the revenue growth expectations for this quarter?

Revenue growth is critical for assessing the company's market performance and future outlook, especially in a competitive health care environment.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate the impact of new product launches that could drive higher-than-expected revenue growth this quarter.

Supporting Evidence

The company has a strong track record of beating EPS estimates, suggesting potential for another surprise.

Options pricing indicates a significant expected move, which may reflect underlying bullish sentiment not captured in analyst estimates.

Key Risk

If revenue growth significantly outpaces expectations, it could challenge the current consensus view.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it will reflect the company's resilience in a challenging market and its ability to capitalize on growth opportunities.

Bull Confirmed If

An EPS of $1.15 or higher would confirm strong operational performance and investor confidence.

Bear Confirmed If

An EPS below $1.05 would raise concerns about the company's ability to maintain profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±10.43%

Historical Avg

±0.9%

Pricing rich

The options market is pricing in a significant move in either direction, indicating that traders expect volatility around the earnings report.

Options are pricing ±10.4% while COO has averaged ±0.9% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

23.8%

Calls (34K)P/C Ratio: 3.83Puts (11K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cooper Companies beats expectations, history suggests a potential stock increase of around 0.95%, confirming strong operational strength.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss could lead to a decline in stock price, with historical data suggesting a potential drop of around 0.40%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's outlook on market conditions and competitive pressures in the health care sector.
3Details on cost management strategies and their effects on profitability.
4Insights into customer demand trends and how they are influencing sales.
5Any commentary on supply chain stability and its impact on operations.